CRH plc (CRH) Balance Sheet
As of 2026-06-30 (10-Q), CRH plc (CRH) reported total assets of $58.6B, total liabilities of $33.0B and shareholders' equity of $25.1B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $3.0B. Long-term debt: $15.4B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CRHCRH plcFollow CRH — free
—
Price chart with a free account
- Market cap
- 56.5B
- P/E TTM
- 15.0
- Dividend yield
- 1.8%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 7.72 | 5.78 | 5.94 | 6.34 | 3.72 | 4.10 | 3.03 | |
| Receivables | — | — | — | — | 4.30 | 4.51 | 4.82 | 5.18 | 6.78 | |
| Inventory | — | — | — | — | 4.19 | 4.29 | 4.76 | 5.25 | 5.10 | |
| Current assets | 17.40 | 17.26 | 14.98 | 14.04 | 14.83 | 16.89 | 14.08 | 15.25 | 15.75 | |
| Total assets | 46.78 | 47.61 | 44.94 | 44.67 | 45.32 | 47.47 | 50.61 | 58.33 | 58.55 | |
| Current liabilities | 13.47 | 12.87 | 7.47 | 7.58 | 8.04 | 10.01 | 10.30 | 8.75 | 9.98 | |
| Long-term debt | 9.96 | 9.21 | 10.96 | 9.94 | 8.15 | 9.78 | 10.97 | 16.48 | 15.41 | |
| Short-term debt | — | — | — | — | 1.40 | 1.76 | 2.88 | 1.06 | 2.41 | |
| Total liabilities | 27.83 | 27.98 | 24.60 | 23.76 | 22.28 | 25.85 | 27.76 | 32.85 | 33.02 | |
| Shareholders' equity | 18.35 | 19.03 | 20.41 | 21.25 | 22.73 | 21.29 | 22.47 | 25.05 | 25.10 |
USD billions · SEC XBRL
CRH plc — questions
- How much cash does CRH plc have?
- $3.0B in cash and cash equivalents as of 2026-06-30.
- How much debt does CRH plc have?
- $15.4B of long-term debt and $2.4B due within a year as of 2026-06-30.
- What are CRH plc's total assets?
- $58.6B as of 2026-06-30.
- What is CRH plc's shareholders' equity?
- $25.1B as of 2026-06-30.
Every figure on this page comes from CRH plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.